Literature DB >> 26076321

Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.

Yiling Zhang1, Liqiang Feng, Liang Li, Dimin Wang, Chufang Li, Caijun Sun, Pingchao Li, Xuehua Zheng, Yichu Liu, Wei Yang, Xuefeng Niu, Nanshan Zhong, Ling Chen.   

Abstract

Vaccines containing multiple antigens may induce broader immune responses and provide better protection against Mycobacterium tuberculosis (Mtb) infection as compared to a single antigen. However, strategies for incorporating multiple antigens into a single vector and the immunization routes may affect their immunogenicity. In this study, we utilized recombinant adenovirus type 5 (rAd5) as a model vaccine vector, and Ag85A (Rv3804c) and Mtb32 (Rv0125) as model antigens, to comparatively evaluate the influence of codon usage optimization, signal sequence, fusion linkers, and immunization routes on the immunogenicity of tuberculosis (TB) vaccine containing multiple antigens in C57BL/6 mice. We showed that codon-optimized Ag85A and Mtb32 fused with a GSG linker induced the strongest systemic and pulmonary cell-mediated immune (CMI) responses. Strong CMI responses were characterized by the generation of a robust IFN-γ ELISPOT response as well as antigen-specific CD4(+) T and CD8(+) T cells, which secreted mono-, dual-, or multiple cytokines. We also found that subcutaneous (SC) and intranasal (IN)/oral immunization with this candidate vaccine exhibited the strongest boosting effects for Mycobacterium bovis bacille Calmette-Guérin (BCG)-primed systemic and pulmonary CMI responses, respectively. Our results supported that codon optimized Ag85A and Mtb32 fused with a proper linker and immunized through SC and IN/oral routes can generate the strongest systemic and pulmonary CMI responses in BCG-primed mice, which may be particularly important for the design of TB vaccines containing multiple antigens.

Entities:  

Keywords:  APC, Allophycocyanin; BCG, Mycobacterium bovis bacille Calmette-Guérin; BSA, bovine serum album; CMI, cell-mediated immune responses; DAPI, 4′,6-diamidino-2-phenylindole; DMSO, Dimethyl sulfoxide; ELISPOT, Enzyme-linked immune-sorbent spot; FACS, Fluorescence Activated Cell Sorter; FBS, fetal bovine serum; FITC, fluorescein isothiocyanate; HA tag, hemagglutinin tag; HEK, human embryo kidney; ICS, Intracellular cytokine staining; IFN-γ, interferon gamma; IL-2, Interleukin 2; IM, intramuscular; IN, intranasal; Mtb, Mycobacterium tuberculosis; NBT/BCIP, Nitro blue tetrazolium/ 5-Bromo-4-chloro-3-indolyl phosphate; PBS, Phosphate Buffered Saline; PCR, polymerase chain reaction; PE, Phycoerythrin; PerCP, Peridinin-ChlorophylL-Protein Complex; RPMI, Roswell Park Memorial Institute; SC, subcutaneous; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; SFC, spot-forming cells; TB, tuberculosis; TNF-α, tumor necrosis factor α; fusion strategies; immunization routes; immunogenicity; multiple antigens; mycobacterium tuberculosis; rAd5, recombinant adenovirus type 5; tPA, tissue plasminogen activator; vp, viral particles

Mesh:

Substances:

Year:  2015        PMID: 26076321      PMCID: PMC4514253          DOI: 10.1080/21645515.2015.1042193

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  54 in total

1.  Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages.

Authors:  L Y Armitige; C Jagannath; A R Wanger; S J Norris
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein.

Authors:  Scott M Irwin; Angelo A Izzo; Steven W Dow; Y A W Skeiky; Steven G Reed; Mark R Alderson; Ian M Orme
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B.

Authors:  Hyun-Jeong Ko; Sung-Youl Ko; Yeon-Jeong Kim; Eun-Gae Lee; Sang-Nae Cho; Chang-Yuil Kang
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Enhancement of Gag-specific but reduction of Env- and Pol-specific CD8+ T cell responses by simian immunodeficiency virus nonstructural proteins in mice.

Authors:  Yinfeng Zhang; Caijun Sun; Liqiang Feng; Lijun Xiao; Ling Chen
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-14       Impact factor: 2.205

5.  Nonlytic Fc-fused IL-7 synergizes with Mtb32 DNA vaccine to enhance antigen-specific T cell responses in a therapeutic model of tuberculosis.

Authors:  So-Shin Ahn; Bo-Young Jeon; Seong-Jeong Park; Dong-Hoon Choi; Sun-Hwa Ku; Sang-Nae Cho; Young-Chul Sung
Journal:  Vaccine       Date:  2013-04-23       Impact factor: 3.641

Review 6.  Role of innate cytokines in mycobacterial infection.

Authors:  A M Cooper; K D Mayer-Barber; A Sher
Journal:  Mucosal Immunol       Date:  2011-03-23       Impact factor: 7.313

7.  Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.

Authors:  Thomas J Scriba; Michele Tameris; Nazma Mansoor; Erica Smit; Linda van der Merwe; Fatima Isaacs; Alana Keyser; Sizulu Moyo; Nathaniel Brittain; Alison Lawrie; Sebastian Gelderbloem; Ashley Veldsman; Mark Hatherill; Anthony Hawkridge; Adrian V S Hill; Gregory D Hussey; Hassan Mahomed; Helen McShane; Willem A Hanekom
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

8.  A multicistronic DNA vaccine induces significant protection against tuberculosis in mice and offers flexibility in the expressed antigen repertoire.

Authors:  Fayaz-Ahmad Mir; Stefan H E Kaufmann; Ali Nasser Eddine
Journal:  Clin Vaccine Immunol       Date:  2009-08-05

9.  A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.

Authors:  Crystal Y Chen; Dan Huang; Richard C Wang; Ling Shen; Gucheng Zeng; Shuyun Yao; Yun Shen; Lisa Halliday; Jeff Fortman; Milton McAllister; Jim Estep; Robert Hunt; Daphne Vasconcelos; George Du; Steven A Porcelli; Michelle H Larsen; William R Jacobs; Barton F Haynes; Norman L Letvin; Zheng W Chen
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

10.  Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection.

Authors:  Nadia Caccamo; Giuliana Guggino; Serena Meraviglia; Giuseppe Gelsomino; Paola Di Carlo; Lucina Titone; Marialuisa Bocchino; Domenico Galati; Alessandro Matarese; Jan Nouta; Michel R Klein; Alfredo Salerno; Alessandro Sanduzzi; Francesco Dieli; Tom H M Ottenhoff
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

View more
  8 in total

1.  Human Desmoglein-2 and Human CD46 Mediate Human Adenovirus Type 55 Infection, but Human Desmoglein-2 Plays the Major Roles.

Authors:  Ying Feng; Changhua Yi; Xinglong Liu; Linbing Qu; Wan Su; Tao Shu; Xuehua Zheng; Xianmiao Ye; Jia Luo; Mingli Hao; Xikui Sun; Liang Li; Xiaolin Liu; Chenchen Yang; Suhua Guan; Ling Chen; Liqiang Feng
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

Review 2.  Mycobacterium-Induced Th1, Helminths-Induced Th2 Cells and the Potential Vaccine Candidates for Allergic Asthma: Imitation of Natural Infection.

Authors:  Mohamed Hamed Abdelaziz; Xiaoyun Ji; Jie Wan; Fatma A Abouelnazar; Sayed F Abdelwahab; Huaxi Xu
Journal:  Front Immunol       Date:  2021-08-03       Impact factor: 7.561

3.  Transposable Element Bm1645 is a Source of BmAGO2-associated Small RNAs that affect its expression in Bombyx mori.

Authors:  Hongqiang Si; Yunjie Cao; Honglin Zhu; Dan Li; Zhengbing Lv; Qing Sheng; Zuoming Nie
Journal:  BMC Genomics       Date:  2017-02-23       Impact factor: 3.969

4.  Immunization with an adenovirus-vectored TB vaccine containing Ag85A-Mtb32 effectively alleviates allergic asthma.

Authors:  Yiling Zhang; Ying Feng; Liang Li; Xianmiao Ye; Jinlin Wang; Qian Wang; Pingchao Li; Na Li; Xuehua Zheng; Xiang Gao; Chufang Li; Feng Li; Baoqing Sun; Kefang Lai; Zhong Su; Nanshan Zhong; Ling Chen; Liqiang Feng
Journal:  J Mol Med (Berl)       Date:  2018-01-04       Impact factor: 4.599

5.  An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques.

Authors:  Yupeng Feng; Chufang Li; Peiyu Hu; Qian Wang; Xuehua Zheng; Yongkun Zhao; Yi Shi; Songtao Yang; Changhua Yi; Ying Feng; Chunxiu Wu; Linbing Qu; Wei Xu; Yao Li; Caijun Sun; Fu Geroge Gao; Xianzhu Xia; Liqiang Feng; Ling Chen
Journal:  Emerg Microbes Infect       Date:  2018-06-06       Impact factor: 7.163

Review 6.  Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism.

Authors:  Craig Schindewolf; Vineet D Menachery
Journal:  Viruses       Date:  2019-01-17       Impact factor: 5.048

Review 7.  Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis.

Authors:  Wenping Gong; Yan Liang; Xueqiong Wu
Journal:  Biomed Res Int       Date:  2020-01-02       Impact factor: 3.411

8.  Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody.

Authors:  Chao-hui Hao; Qian-he Han; Zhong-jie Shan; Jian-ting Hu; Nan Zhang; Xue-pei Zhang
Journal:  Theor Biol Med Model       Date:  2015-08-06       Impact factor: 2.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.